Literature DB >> 30049196

Estimating the Burden of Cancer and Treatment Cost Related to Alcohol Consumption in Indonesia: a Descriptive Study

Susi Ari Kristina1, Dwi Endarti, Chairun Wiedyaningsih, Agustina Nila Yuliawati, Suzan Astyamalia.   

Abstract

Background: Alcohol consumption has become one of the most common cancer risk factors after smoking. Nowadays, estimation of the burden of disease attributable to alcohol has become standard in documenting the impact of health problems, but it has been rarely performed in Indonesia. The aim of this study was to estimate treatment cost of cancer related to alcohol consumption among the Indonesian population.
Methods: This research design was descriptive with a prevalence-based approach using secondary data. Proportions of cancers were calculated using an alcohol-attributable fractions (AAF) formula. Treatment costs for eight types of cancer were assessed according to average treatment cost per patient from the national universal health coverage database for 2016. Result: The top three AAFs for males were cancers of the pharynx, esophagus and larynx (17.5%, 15.3% and 7.98%, respectively), while in females they were cancers of the esophagus, pharynx and stomach (2.15%; 1.39%; 0.83%). Among the eight types of cancer studied, the highest incidence in males was noted for liver cancer (132 cases) while colorectal cancer was the most common among females (31 cases). Treatment cost for cancers related to alcohol consumption were highest for colorectak cancer followed by laryngeal and liver cancer (116,083, 98,325 and 93,253 USD, respectively.
Conclusion: The expenditure for treatment of cancers related to alcohol consumption accounts for about 1.71% of total cancer treatment cost. Since cancers related to alcohol consumption can be considered having an economic impact in Indonesia, it becomes important for the government to control alcohol consumption so that related healthcare expenditure can be minimized. Creative Commons Attribution License

Entities:  

Keywords:  Alcohol; cancer; treatment cost; Indonesia

Mesh:

Year:  2018        PMID: 30049196      PMCID: PMC6165643          DOI: 10.22034/APJCP.2018.19.7.1845

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


Introduction

Alcohol consumption is one of the addictive behaviors which became major contributors to the global burden of morbidity and premature death (Global Burden of Disease Cancer Collaboration, 2017). Impact of alcohol on cancer have been increased from 4% to about 25% of the diseases burden worldwide (Gowing et al., 2015). Based on WHO Global Status Report on Alcohol 2014, cancer became one of the major causes of morbidity and mortality throughout the world, with about 14 million new cases and 8.2 million death-related cancer (Bosque-Prous et al., 2017). In 2015, cancer caused over 8.7 million deaths globally and was the second leading cause of death behind cardiovascular diseases (Global Burden of Disease Cancer Collaboration, 2017). A meta-analysis study done by Bagnardi et al showed there was association of cancers and level of alcohol drinking, which was represented by relative risk of cancer with intake of levels of alcohol, ranged from 1.14 to 8.32 (Bagnardi et al., 2015). Cancer is considered as the most significant contributors of health care spending in the United States; as well treatment of cancer requires substantial funds (Chang et al., 2004). Health care spending in Europe during 1995-2014 was increasing continuously; it was estimated to be €35.7 billion in 1995 which increased to €83.2 billion in 2014 (Jönsson et al., 2016) Alcohol prevalence as well as economic burden of alcohol remains higher in Asian countries like Thailand, Taiwan, and China (Nganthavee, 2007; Liang et al., 2010; Thavorncharoensap et al., 2010; Hung et al., 2016). According to WHO, the prevalence of alcohol consumption among the Indonesian population was about 7.1% (World Health Organization, 2014a). Over the past few decades, alcohol prevalence substantially higher in Indonesian adult men and also in women (Ministry of Health, 2013). Research on the burden of diseases especially cancers related to alcohol is not yet done in developing countries like Indonesia. Therefore, the aim of this study was to estimate the burden of cancer and treatment cost related to alcohol consumption among Indonesia population at the national level.

Materials and Methods

This research was secondary data study by using estimation prevalence-based with detail of diseases (Pérez-Ríos and Montes, 2008). Calculation of treatment cost based on concept of cost of illness by using governmental perspective. Direct estimates of morbidity cannot be made because there is a lack of longitudinal studies on the differential morbidity of alcohol drinkers, light, moderate, and heavy drinker, necessary to provide RR estimates for alcohol-related diseases. Original method proposed by Peto et al., (1992) requires incidence rates in those who did not expose risk factor, which are not available in Indonesia.

The alcohol consumption prevalence

The prevalence of drinkers in Indonesia was obtained from the WHO Global Status Report on Alcohol and Health 2014. The report contained data on the prevalence of alcohol use, heavy drinker status among the Indonesia population for > 15 years of age was 4.9% among male and 0.3% among the female (World Health Organization, 2014a).

Relative risk

Relative risk (RR) was calculated as per meta-analysis study associated with alcohol use and risk of cancer (Bagnardi et al., 2015). In our study RR was calculated for heavy intake of alcohol consumption adjusted with the available prevalence of data on alcohol consumption.

Determination of cancer related to alcohol consumption

The study included risks of 8 types of cancer like cancer of oral cavity, pharynx, esophagus, stomach, colorectum, liver, pancreas, larynx and lung with alcohol consumption. The data obtained was adjusted to the data available with BPJS 2016 (Indonesian Universal Health Coverage (BPJS), 2016) and RR from the meta-analysis study and alcohol-attributable fraction was calculated.

Incidence number of cancers

Incidence number of eight types of cancers was retrieved through secondary data from BPJS 2016 (Indonesian Universal Health Coverage (BPJS), 2016).

Estimation alcohol-attributable fractions (AAFs) and morbidity

AAFs represent the proportion of morbidity due to alcohol with the following formula: AAF where: i = exposure category with the initial exposure or no exposure (i = 0); RRi = the relative risk exposure at the level i compared with no consumption; Pi = the prevalence or incidence of exposure category (Rehm et al., 2009). Then, incidence number or morbidity of cancer related to alcohol consumption (AAI) can be calculated by the formula: Where: AAF = alcohol-attributable fraction of cancers; I = morbidity (incidence number) of type of cancers.

Calculation treatment cost of cancer related to alcohol consumption

The direct costs of all cancers treatment for this study was obtained from the data of the National BPJS 2016. Treatment cost of cancers related to alcohol consumption was calculated by multiplying AAI with the treatment cost of cancer per patient.

Sensitivity analysis

One-way sensitivity analysis has done in an effort to identify the variables that potentially lead to significant changes in the results of the study. Variation of prevalence of alcohol consumption and relatives risk had assessed using one-way sensitivity analysis.

Results

In the study, highest AAFs among males were seen for cancer of pharynx (17.50%) followed by cancer of esophagus and larynx and among females it was seen for cancer of esophagus (2.15%) followed by cancer of pharynx and stomach (Table 1).
Table 1

The Proportion of Eight Types of Cancer Related to Alcohol Consumption on Alcohol-Attributable Fractions (AAFs)

No.Cancer codeICD-10RR*AAFs (%)
MaleFemaleMaleFemale
1ColorectumC 18-211.533.232.530.66
2EsophagealC 154.698.3215.312.15
3LarynxC 322.771.557.980.16
4LiverC 221.591.242.810.07
5PharynxC 00-145.335.717.51.39
6PancreasC 251.161.170.780.05
7LungC 33-341.141.20.680.06
8StomachC 161.23.80.970.83

RRs were obtained from Bagnardi (Bagnardi V et al., 2015)

The Proportion of Eight Types of Cancer Related to Alcohol Consumption on Alcohol-Attributable Fractions (AAFs) RRs were obtained from Bagnardi (Bagnardi V et al., 2015) In the study, highest AAM among males were seen for liver cancer (215 cases) followed by colorectal cancer and cancer of larynx (132 and 104 cases) respectively and among females it was seen for cancer of colorectum (31cases) followed by cancer of stomach, lung and esophagus (5, 3, and 3) respectively (Table 2).
Table 2

Number of Mortality (NOM) and Alcohol-Attributable Morbidity (AAM) of Eight Types of Cancer Related to Alcohol Consumption in Indonesia 2016

NoCancersICD-10NOMAAM
MaleFemaleMaleFemaleTotal
1ColorectumC 18-215,2044,63613231163
2EsophagusC 1528814544347
3LarynxC 321,3053141041105
4LiverC 227,6493,3582152217
5PharynxC 00-141449325126
6PancreasC 251,0138998N/A8
7LungC 33-347,8794,22054356
8StomachC 164416484510
Total23.92314.31358647632
% of eight types of cancer2.45%0.33%1.65%

NOM, Number of mortality; AAM, Alcohol-attributable mortality; N/A, not available

Number of Mortality (NOM) and Alcohol-Attributable Morbidity (AAM) of Eight Types of Cancer Related to Alcohol Consumption in Indonesia 2016 NOM, Number of mortality; AAM, Alcohol-attributable mortality; N/A, not available Among the treatment cost, the total cost of cancer-related to alcohol consumption was highest among males (3, 88,952.19 USD) as compared to females (27,275.15 USD). Treatment costs among the 8 types of cancer-related to alcohol consumption among males were cancer of larynx which topped the list with 98.107.12 USD followed by colorectal and liver cancer (95,170.89 and 92,305.23 USD) respectively and among the females were colorectal cancer (20,912.48 USD) topped the list, followed by lung and esophageal cancer (1,839.08 and 1,494.34 USD) respectively. Overall, the highest total treatment cost of cancer-related to alcohol consumption especially in heavy level intake of alcohol was seen for colorectal cancer (116,083.37 USD) followed by cancer of larynx and liver (98,324.93 and 93,253.29 USD) respectively. One-way sensitivity used by changing prevalence of alcohol consumption and relative risk of eight types of cancer related to alcohol consumption. Table 4 show prevalence changes by decreasing prevalence about 1%, 3% and 5% then, also increasing prevalence about 5%, 10%, and 20%. Total Treatment Cost of Eight Types of Cancer Related to Alcohol Consumption in Indonesia 2016 N/A, not available; 1 USD, IDR 13,369 (based on http:/www.bi.go.id/moneter/informasi-kurs/transaksi-bi/Default.aspx per December 31st, 2016); Data Changes Due to Prevalance Alternative

Discussion

Our study was the first study done in Indonesia to estimate the treatment cost of cancers related to alcohol consumption. Our study described the burden of cancer-related to alcohol consumption and would become a baseline study for the government to have control measures related to alcohol consumption so as to reduce the harmful effects of alcohol consumption. Alcohol was responsible for 1.65% of all cancer cases and treatment cost of cancer-related to alcohol consumption was seen highest in colorectum cancer followed by larynx and liver cancer in USD (116,083, 98,325 and 93,253) respectively. Prevalence of cancers both in male and female has similarity on three top cancer, there were cancer of lung, liver, and colorectum. When compared to Globocan data 2012, estimated prevalence number of cancers on three top places in Indonesia also occupied by cancer of lung in first place (16.3% of total incidence of cancer in Indonesia) then followed by cancer of colorectum (12.8%), and liver (8.4%) (World Health Organization, 2014b). Eight types of cancer in Indonesia both in male and female majority occurred in elderly population. Based on WHO data, life expectancy of the Indonesia population that is surviving at older ages in 2015 was about 67 years for male and 71 years for female. Age significantly increases the risk of cancer. In elderly people, other lifestyle that associated risks will also accumulated. The risk factors for the most common cancers have a long time to impact and increase the risk of disease in older people. A study explained that the incidence of most cancers increases with age, rising more rapidly beginning in midlife (45-64 years) (Whiteman and Wilson, 2016). Based on previous research, mechanism of the increase in cancer risk with age was related to dose-duration effect of carcinogenic exposures (Scoccianti et al., 2015). AAFs was aimed to estimate the proportion of each cancer cases related to alcohol consumption. The highest AAFs in male is 17.50% can be interpreted that the proportion of pharynx cancer related to alcohol consumption is about 17.50% then followed by esophageal cancer (15.18%) and larynx cancer (7.91%). Then, for female, the highest AAFs is 2.15% can be interpreted that the proportion of esophageal cancer related to alcohol consumption is about 2.15%, then followed by pharynx cancer (1.39%) and stomach cancer (0.83%). From here, it can be showed that AAFs value in female smaller than male because the prevalence of heavy drinker in female is less than male. Morbidity of eight types of cancer related to alcohol in male was higher than female, it was about 586 cases in male (2.45% of total incidence of eight types of cancer) and 47 cases (0.33% of total incidence of eight types of cancer). This was in accordance with prevalence of alcohol consumption higher in male than female. Overall, liver cancer have highest AAM that showed number of case of liver cancer due to alcohol consumption, it was about 217 cases (1.98% of total incidence of liver cancer), then followed by colorectum cancer (163 cases), and larynx cancer (105 cases). These trend was also happened in China, a study by Liang et al., (2010), showed that liver cancer was the main alcohol-related cancer, contributing more than 60% of alcohol-related cancer with total incidence number of liver cancer due to alcohol consumption. Among Korean women, the AAF for colorectal cancer incidence was the highest (4.2%) and about 0.5% (464 cancer cases) of incident cancers were attributable to alcohol consumption (Park et al., 2014). Based on research by Chang et al. (2017) examined about the association between alcohol and cancer in Asian people has been stating that ALDH2 polymorphism (ALDH2*2 allele) was responsible and play a role in causing cancer related to alcohol (Chang et al., 2017). López-Lázaro (2016) also explained there was a local mechanism of alcohol causing cancer. Ethanol that presenting in alcoholic beverages can causes a local cytotoxic effect in cells lining until cell death happened when the ethanol was passing the epithelial tissues such as in oral cavity, pharynx and esophagus. Treatment cost of eight types of cancer related to alcohol consumption analyzed by calculating the direct treatment cost of eight types of cancer in Indonesia 2016. Total treatment cost of cancer related to alcohol consumption in 2016 was about 416,227.34 USD or 1.71% of total treatment of eight types of cancer. It was about 0.008% of total healthcare expenditure by government in 2016. Our finding was similar with previous research conducted in Thailand. The direct cost on health care was about 5,491.2 million Bath including treatment cost for laryngeal cancer, liver cancer, mouth and oropharynx cancer, esophageal cancer, stomach cancer and other diseases (Thavorncharoensap et al., 2010). Chemotherapy and radiation therapy use were the common largest cost of cancer treatment (Warren et al., 2008). According to Basic Health Survey report 2013, cancer as a non-communicable diseases (NCDs) has prevalence data less than among other NCDs such as asthma and chronic obstructive pulmonary disease (COPD) (Ministry of Health, 2013). Even cancer prevalence less than others, but cancer classified as catastrophic diseases which has the characteristics of high cost and high risk of death, then actually much cost spent on cancer treatment. Like developing countries, developed countries also explained cancer is among the most significant contributors of healthcare spending, with direct treatment cost in 2002 at 60.9 billion USD (Chang et al., 2004), in 2006 spent healthcare cost about 11% (Bouchery et al., 2011) then in 2014 has increased to 87.7 billion USD (American Cancer Society, 2017). Interventions such as increased excise taxes, educational approaches highlighted the dangers of alcohol use are the most cost-effective intervention to reduce alcohol use (Kelly-Weeder et al., 2011). Then policy initiatives such as imposing punishment and prohibition for inebriation to reduce prevalence of alcohol consumption (Lai et al., 2007). However, some limitations of the study need to be discussed. This result could be said to be under estimation with real cost because of some factors including the number of participants covered by national insurer was about 70% of total Indonesia population. In addition, not all participants utilize the health services offered by BPJS, for example some cancer patients prefer to use alternative treatment such as traditional medicine rather than formal health care services. Another limitation is relative risk (RR) has been used in this research was not from Indonesia then it could not represented fully of Indonesia’s cancer condition which is affected by demographic differences, and comorbidity disease beside cancer affected by other lifestyles. Our finding could be considered by government to reduce healthcare expenditure of cancer related to alcohol wherefore the prevalence of alcohol consumption has increased in recent years. Despite these limitations, our results show the importance and the priority to be accorded to reduce the rate of alcohol consumption in the Indonesian population. A reduction in alcohol consumption would decrease the cancer burden and a significant impact is anticipated specifically for healthcare cost related to alcohol consumption.
Table 3

Total Treatment Cost of Eight Types of Cancer Related to Alcohol Consumption in Indonesia 2016

CancerICD-10 codeMaleFemaleTotal of treatment cost (USD)
AAMTreatment cost (USD)AAMTreatment cost (USD)
ColorectumC 18-2113295,170.893120,912.48116,083.37
EsophagealC 154442,326.2631,494.3443,820.60
LarynxC 3210498,107.121217.8198,324.93
LiverC 2221592,305.232948.0693,253.29
PharynxC 00-142510,830.101203.5911,033.69
PancreasC 2585,613.22N/AN/A5,613.22
LungC 33-345442,997.7631,839.0844,836.84
StomachC 1641,601.6151,340.672,942.28
Total586388,952.194727,275.15416,227.34

N/A, not available; 1 USD, IDR 13,369 (based on http:/www.bi.go.id/moneter/informasi-kurs/transaksi-bi/Default.aspx per December 31st, 2016);

Table 4

Data Changes Due to Prevalance Alternative

PrevalenceAAF (%)AAM (%)Total treatment cost (%)
MaleFemaleMaleFemaleMaleFemale
Deccreased 1%-0.9-1-1-1-0.9-1
Decreased 3%-2.6-3-2.9-3-2.8-3
Decreased 5%-4.4-4.9-4.8-5-4.7-5
Increased 5%4.34.94.754.75
Increased 10%8.69.89.59.99.49.9
Increased 20%1719.718.819.818.719.8
  20 in total

1.  The cost and burden of cancer in the European Union 1995-2014.

Authors:  Bengt Jönsson; Thomas Hofmarcher; Peter Lindgren; Nils Wilking
Journal:  Eur J Cancer       Date:  2016-08-31       Impact factor: 9.162

2.  A local mechanism by which alcohol consumption causes cancer.

Authors:  Miguel López-Lázaro
Journal:  Oral Oncol       Date:  2016-10-05       Impact factor: 5.337

3.  Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000.

Authors:  Stella Chang; Stacey R Long; Lucie Kutikova; Lee Bowman; Denise Finley; William H Crown; Charles L Bennett
Journal:  J Clin Oncol       Date:  2004-09-01       Impact factor: 44.544

4.  Mortality from tobacco in developed countries: indirect estimation from national vital statistics.

Authors:  R Peto; A D Lopez; J Boreham; M Thun; C Heath
Journal:  Lancet       Date:  1992-05-23       Impact factor: 79.321

5.  Global statistics on addictive behaviours: 2014 status report.

Authors:  Linda R Gowing; Robert L Ali; Steve Allsop; John Marsden; Elizabeth E Turf; Robert West; John Witton
Journal:  Addiction       Date:  2015-06       Impact factor: 6.526

6.  Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis.

Authors:  V Bagnardi; M Rota; E Botteri; I Tramacere; F Islami; V Fedirko; L Scotti; M Jenab; F Turati; E Pasquali; C Pelucchi; C Galeone; R Bellocco; E Negri; G Corrao; P Boffetta; C La Vecchia
Journal:  Br J Cancer       Date:  2014-11-25       Impact factor: 7.640

Review 7.  ALDH2 polymorphism and alcohol-related cancers in Asians: a public health perspective.

Authors:  Jeffrey S Chang; Jenn-Ren Hsiao; Che-Hong Chen
Journal:  J Biomed Sci       Date:  2017-03-03       Impact factor: 8.410

8.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.

Authors:  Christina Fitzmaurice; Christine Allen; Ryan M Barber; Lars Barregard; Zulfiqar A Bhutta; Hermann Brenner; Daniel J Dicker; Odgerel Chimed-Orchir; Rakhi Dandona; Lalit Dandona; Tom Fleming; Mohammad H Forouzanfar; Jamie Hancock; Roderick J Hay; Rachel Hunter-Merrill; Chantal Huynh; H Dean Hosgood; Catherine O Johnson; Jost B Jonas; Jagdish Khubchandani; G Anil Kumar; Michael Kutz; Qing Lan; Heidi J Larson; Xiaofeng Liang; Stephen S Lim; Alan D Lopez; Michael F MacIntyre; Laurie Marczak; Neal Marquez; Ali H Mokdad; Christine Pinho; Farshad Pourmalek; Joshua A Salomon; Juan Ramon Sanabria; Logan Sandar; Benn Sartorius; Stephen M Schwartz; Katya A Shackelford; Kenji Shibuya; Jeff Stanaway; Caitlyn Steiner; Jiandong Sun; Ken Takahashi; Stein Emil Vollset; Theo Vos; Joseph A Wagner; Haidong Wang; Ronny Westerman; Hajo Zeeb; Leo Zoeckler; Foad Abd-Allah; Muktar Beshir Ahmed; Samer Alabed; Noore K Alam; Saleh Fahed Aldhahri; Girma Alem; Mulubirhan Assefa Alemayohu; Raghib Ali; Rajaa Al-Raddadi; Azmeraw Amare; Yaw Amoako; Al Artaman; Hamid Asayesh; Niguse Atnafu; Ashish Awasthi; Huda Ba Saleem; Aleksandra Barac; Neeraj Bedi; Isabela Bensenor; Adugnaw Berhane; Eduardo Bernabé; Balem Betsu; Agnes Binagwaho; Dube Boneya; Ismael Campos-Nonato; Carlos Castañeda-Orjuela; Ferrán Catalá-López; Peggy Chiang; Chioma Chibueze; Abdulaal Chitheer; Jee-Young Choi; Benjamin Cowie; Solomon Damtew; José das Neves; Suhojit Dey; Samath Dharmaratne; Preet Dhillon; Eric Ding; Tim Driscoll; Donatus Ekwueme; Aman Yesuf Endries; Maryam Farvid; Farshad Farzadfar; Joao Fernandes; Florian Fischer; Tsegaye Tewelde G/Hiwot; Alemseged Gebru; Sameer Gopalani; Alemayehu Hailu; Masako Horino; Nobuyuki Horita; Abdullatif Husseini; Inge Huybrechts; Manami Inoue; Farhad Islami; Mihajlo Jakovljevic; Spencer James; Mehdi Javanbakht; Sun Ha Jee; Amir Kasaeian; Muktar Sano Kedir; Yousef S Khader; Young-Ho Khang; Daniel Kim; James Leigh; Shai Linn; Raimundas Lunevicius; Hassan Magdy Abd El Razek; Reza Malekzadeh; Deborah Carvalho Malta; Wagner Marcenes; Desalegn Markos; Yohannes A Melaku; Kidanu G Meles; Walter Mendoza; Desalegn Tadese Mengiste; Tuomo J Meretoja; Ted R Miller; Karzan Abdulmuhsin Mohammad; Alireza Mohammadi; Shafiu Mohammed; Maziar Moradi-Lakeh; Gabriele Nagel; Devina Nand; Quyen Le Nguyen; Sandra Nolte; Felix A Ogbo; Kelechi E Oladimeji; Eyal Oren; Mahesh Pa; Eun-Kee Park; David M Pereira; Dietrich Plass; Mostafa Qorbani; Amir Radfar; Anwar Rafay; Mahfuzar Rahman; Saleem M Rana; Kjetil Søreide; Maheswar Satpathy; Monika Sawhney; Sadaf G Sepanlou; Masood Ali Shaikh; Jun She; Ivy Shiue; Hirbo Roba Shore; Mark G Shrime; Samuel So; Samir Soneji; Vasiliki Stathopoulou; Konstantinos Stroumpoulis; Muawiyyah Babale Sufiyan; Bryan L Sykes; Rafael Tabarés-Seisdedos; Fentaw Tadese; Bemnet Amare Tedla; Gizachew Assefa Tessema; J S Thakur; Bach Xuan Tran; Kingsley Nnanna Ukwaja; Benjamin S Chudi Uzochukwu; Vasiliy Victorovich Vlassov; Elisabete Weiderpass; Mamo Wubshet Terefe; Henock Gebremedhin Yebyo; Hassen Hamid Yimam; Naohiro Yonemoto; Mustafa Z Younis; Chuanhua Yu; Zoubida Zaidi; Maysaa El Sayed Zaki; Zerihun Menlkalew Zenebe; Christopher J L Murray; Mohsen Naghavi
Journal:  JAMA Oncol       Date:  2017-04-01       Impact factor: 31.777

Review 9.  Methodologies used to estimate tobacco-attributable mortality: a review.

Authors:  Mónica Pérez-Ríos; Agustín Montes
Journal:  BMC Public Health       Date:  2008-01-22       Impact factor: 3.295

10.  Attributable fraction of alcohol consumption on cancer using population-based nationwide cancer incidence and mortality data in the Republic of Korea.

Authors:  Sohee Park; Hai-Rim Shin; Boram Lee; Aesun Shin; Kyu-Won Jung; Duk-Hee Lee; Sun Ha Jee; Sung-Il Cho; Sue Kyung Park; Mathieu Boniol; Paolo Boffetta; Elisabete Weiderpass
Journal:  BMC Cancer       Date:  2014-06-10       Impact factor: 4.430

View more
  2 in total

1.  Global burden of larynx cancer, 1990-2017: estimates from the global burden of disease 2017 study.

Authors:  Yujiao Deng; Meng Wang; Linghui Zhou; Yi Zheng; Na Li; Tian Tian; Zhen Zhai; Si Yang; Qian Hao; Ying Wu; Dingli Song; Dai Zhang; Jun Lyu; Zhijun Dai
Journal:  Aging (Albany NY)       Date:  2020-02-08       Impact factor: 5.682

2.  Use of Chemoradiotherapy as a Treatment Option for Patients with Limited-Stage Primary Small Cell Carcinoma of the Esophagus.

Authors:  Kaikai Zhao; Zhaoqin Huang; Youjiao Si; Liangchao Sun; Jinming Yu; Xiangjiao Meng
Journal:  Cancer Manag Res       Date:  2021-01-25       Impact factor: 3.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.